Project Title | Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate |
Date Posted |
Monday, March 19, 2018 |
Project ID |
TO16_CAP_STR_WP001-002_NSDP_V01 |
Status |
Complete |
Deliverables | |
Description |
These reports investigate counts and prevalent use of drug products and procedures in the Mini-Sentinel Distributed Database (MSDD). Report 1 includes prevalence of 11 drug products and Report 2 includes counts and prevalence of 11 Healthcare Common Procedure Coding System (HCPCS) procedure codes. Results were generated using the Mini-Sentinel Distributed Query Tool. Queries were run against the Dispensing Summary Table and distributed on October 30, 2014 to 14 Data Partners; this report includes information from 14 Data Partners. |
Medical Product |
alendronate sodium alendronate sodium/vitamin d3 bandronate sodium calcitonin salmon calcitonin, salmon, synthetic denosumab ibandronate sodium raloxifene HCL risedronate sodium risedronate sodium/calcium carbonate teriparatide zoledronic acid zoledronic acid reclast zoledronic acid/mannitol and water zoledroniccid reclast zoledroniccid zometa |
Population / Cohort |
All individuals |
Time Period |
2006-2014 |
Assessment Type |
Exploratory Analyses |
Study Type |
Summary Table |
Data Sources |
Mini-Sentinel Distributed Database (MSDD) |
FDA Center |
CDER |